ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $12,055,000 | +6416.2% | 260,196 | +1697.6% | 0.09% | +8700.0% |
Q4 2017 | $185,000 | -92.3% | 14,475 | -95.0% | 0.00% | -93.8% |
Q2 2017 | $2,406,000 | +11.2% | 287,449 | +18.8% | 0.02% | -5.9% |
Q1 2017 | $2,164,000 | +525.4% | 242,012 | +372.5% | 0.02% | +750.0% |
Q3 2016 | $346,000 | +686.4% | 51,220 | +389.0% | 0.00% | – |
Q4 2015 | $44,000 | -82.5% | 10,475 | -79.0% | 0.00% | -100.0% |
Q4 2013 | $251,000 | -45.0% | 50,000 | -50.2% | 0.00% | -60.0% |
Q2 2013 | $456,000 | – | 100,387 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
FBR & Co. | 113,500 | $706,000 | 1.07% |
Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |